Psychiatry Stocks List

Psychiatry Stocks Recent News

Date Stock Title
Nov 1 NXL Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th
Nov 1 NXL Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
Nov 1 NXL LOBO EV and Nexalin Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Nov 1 ITCI Intra-Cellular Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Oct 31 SAVA Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024
Oct 31 ITCI Intra-Cellular Therapies Inc (ITCI) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ...
Oct 30 ITCI Intra-Cellular Therapies, Inc. (ITCI) Q3 2024 Earnings Call Transcript
Oct 30 ITCI Intra-Cellular jumps on Q3 beat as Caplyta outlook brightens
Oct 30 ITCI ITCI Q3 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales
Oct 30 SAVA Institutions along with individual investors who hold considerable shares inCassava Sciences, Inc. (NASDAQ:SAVA) come under pressure; lose 6.7% of holdings value
Oct 30 ITCI Intra-Cellular Therapies (ITCI) Reports Q3 Loss, Tops Revenue Estimates
Oct 30 ITCI Intra-Cellular: Q3 Earnings Snapshot
Oct 30 ITCI Intra-Cellular Therapies GAAP EPS of -$0.25 misses by $0.04, revenue of $175.4M beats by $3.05M
Oct 30 ITCI Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance
Oct 30 PRTC PureTech to Present at Two Upcoming Investor Conferences
Oct 29 ITCI Intra-Cellular Therapies Q3 2024 Earnings Preview
Oct 28 SAVA MIRA Pharmaceuticals' Formulated Shows Greater Efficacy Than FDA-Approved Drug For Chemo-Induced Neuropathic Pain
Oct 28 NXL Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease
Oct 28 NXL EXCLUSIVE: Nexalin Technology Says New Data Confirms Implantable Device Improves Cognitive Function, Restores Brain Activity in Alzheimer's Patients
Oct 27 RGC Regencell Bioscience Holdings (NASDAQ:RGC) Is In A Good Position To Deliver On Growth Plans
Psychiatry

Psychiatry is the medical specialty devoted to the diagnosis, prevention and treatment of mental disorders. These include various maladaptations related to mood, behaviour, cognition, and perceptions. See glossary of psychiatry.
Initial psychiatric assessment of a person typically begins with a case history and mental status examination. Physical examinations and psychological tests may be conducted. On occasion, neuroimaging or other neurophysiological techniques are used. Mental disorders are often diagnosed in accordance with clinical concepts listed in diagnostic manuals such as the International Classification of Diseases (ICD), edited and used by the World Health Organization (WHO) and the widely used Diagnostic and Statistical Manual of Mental Disorders (DSM), published by the American Psychiatric Association (APA). The fifth edition of the DSM (DSM-5) was published in 2013 which re-organized the larger categories of various diseases and expanded upon the previous edition to include information/insights that are consistent with current research.The combined treatment of psychiatric medication and psychotherapy has become the most common mode of psychiatric treatment in current practice, but contemporary practice also includes a wide variety of other modalities, e.g., assertive community treatment, community reinforcement, and supported employment. Treatment may be delivered on an inpatient or outpatient basis, depending on the severity of functional impairment or on other aspects of the disorder in question. An inpatient may be treated in a psychiatric hospital. Research and treatment within psychiatry as a whole are conducted on an interdisciplinary basis (e.g., with epidemiologists, mental health counselors, nurses, psychologists, public health specialists, radiologists or social workers).

Browse All Tags